Compounding pharmacy sues Lilly, Novo over GLP-1 drug competition
Arizona-based Strive Compounding Pharmacy has sued Eli Lilly (LLY) and Novo Nordisk (NVO) in a Texas federal court alleging...
Tag: LLY
FDA asks Lilly, Novo to remove suicide warning related to GLP-1 obesity drugs
The U.S. FDA on Tuesday requested Novo Nordisk (NVO) and Eli Lilly (LLY) to implement labeling changes for their blockbuster...
Novo Nordisk CEO says up to 1.5M Americans are on compounded GLP-1s
Novo Nordisk (NVO) CEO Mike Doustdar says that up to 1.5M patients in the U.S. could be using compounded versions of GLP-1...
4 stocks to watch on Tuesday: JPM, LLY, USB, PANW
Stock index futures rose on Tuesday as core CPI inflation came in slightly cooler than expected. Here are the four stocks to...
Eli Lilly CFO says obesity pill on track for FDA nod in Q2
In an interview with Bloomberg News, Eli Lilly Chief Financial Officer Lucas Montarce said that the Indiana-based pharma...
Eli Lilly says it has plenty of supply for orforglipron launch – report
With the likely approval of Eli Lilly's new weight loss pill, orforglipron, coming this quarter, a top executive said that...
Abivax jumps on report Eli Lilly readying EU15B takeover bid
Abivax (ABVX) ADRs rose 23% in premarket trading after a report that Eli Lilly (LLY) is preparing to offer €15 billion for...
Lilly partner Aktis surges on trading debut
Clinical-stage biotech Aktis Oncology (AKTS), which counts Eli Lilly (LLY) among its partners, traded sharply higher after...
Eli Lilly in pact with Schrödinger in AI-related drug discovery
Schrödinger (SDGR) on Friday announced a collaboration with Eli Lilly (LLY) to integrate its drug development software...
Lilly trial finds psoriatric arthritis, weight improvement in Taltz + Zepbound combo
A phase 3b trial examining Eli Lilly's (LLY) Taltz (ixekizumab) along with Zepbound (tirzepatide) led to positive outcomes...